Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Ischemic Heart Disease

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 28 articles: HTML format

Single Articles

November 2021
1. BLASCO A, Coronado MJ, Vela P, Martin P, et al
   Prognostic implications of Neutrophil Extracellular Traps in coronary thrombi of patients with ST-elevation myocardial infarction.
   Thromb Haemost. 2021 Nov 30. doi: 10.1055/a-1709-5271.
   PubMed     Abstract available
   
   
   October 2021
2. BOJIC M, Bielesz B, Cejka D, Schernthaner GH, et al
   Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery Disease.
   Thromb Haemost. 2021 Oct 31. doi: 10.1055/s-0041-1736444.
   PubMed     Abstract available
   
   
   
3. MCCUTCHEON K, Manga P
   Human Immunodeficiency Virus and Cardiovascular Disease: Revisiting the Inflammation-Thrombosis Axis.
   Thromb Haemost. 2021 Oct 24. doi: 10.1055/s-0041-1736445.
   PubMed    
   
   
   
4. CALDERONE D, Greco A, Ingala S, Agnello F, et al
   Efficacy and safety of aspirin for cardiovascular risk prevention in younger and older age: an updated systematic review and meta-analysis.
   Thromb Haemost. 2021 Oct 12. doi: 10.1055/a-1667-7427.
   PubMed     Abstract available
   
   
   September 2021
5. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
   The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
   Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
   PubMed     Abstract available
   
   
   June 2021
6. PEDERSEN OB, Grove EL, Kristensen SD, Nissen PH, et al
   MicroRNA as Biomarkers for Platelet Function and Maturity in Patients with Cardiovascular Disease.
   Thromb Haemost. 2021 Jun 6. doi: 10.1055/s-0041-1730375.
   PubMed     Abstract available
   
   
   May 2021
7. HALLY KE, Parker OM, Brunton-O'Sullivan MM, Harding SA, et al
   Linking Neutrophil Extracellular Traps and Platelet Activation: A Composite Biomarker Score for Predicting Outcomes after Acute Myocardial Infarction.
   Thromb Haemost. 2021 May 13. doi: 10.1055/s-0041-1728763.
   PubMed     Abstract available
   
   
   March 2021
8. FABRIS E, Korjian S, Coller B, Ten Berg JM, et al
   Pre-Hospital Antiplatelet Therapy for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: What We Know and What Lies Ahead.
   Thromb Haemost. 2021 Mar 7. doi: 10.1055/a-1414-5009.
   PubMed     Abstract available
   
   
   February 2021
9. YAMASHITA A, Nishihira K, Gi T, Maekawa K, et al
   Pathological Features of Ruptured Coronary Plaque and Thrombus Interfaces: Fibrin and von Willebrand Factor as Platelet Scaffolds on Rupture Sites.
   Thromb Haemost. 2021;121:234-241.
   PubMed     Abstract available
   
   
   
10. VAN PARIDON PCS, Panova-Noeva M, van Oerle R, Schulz A, et al
    Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
    Thromb Haemost. 2021;121:174-181.
    PubMed     Abstract available
    
    
    January 2021
11. GUEDENEY P, Collet JP
    Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management.
    Thromb Haemost. 2021 Jan 27. doi: 10.1055/s-0040-1722188.
    PubMed     Abstract available
    
    
    
12. HENNING C, Branopolski A, Follert P, Lewandowska O, et al
    Endothelial beta1 Integrin-Mediated Adaptation to Myocardial Ischemia.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1721505.
    PubMed     Abstract available
    
    
    
13. STOJKOVIC S, Wadowski PP, Haider P, Weikert C, et al
    Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722226.
    PubMed     Abstract available
    
    
    December 2020
14. AZNAOURIDIS K, Tselegkidi ME, Kanakakis I, Alexopoulos D, et al
    Dual Antithrombotic Therapy in Atrial Fibrillation Patients undergoing Percutaneous Coronary Angioplasty: The Impact of Bleeding Risk Score on Outcome.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721777.
    PubMed    
    
    
    
15. ARROYO AB, Aguila S, Fernandez-Perez MP, DE Los Reyes-Garcia AM, et al
    miR-146a in cardiovascular diseases and sepsis: an additional burden in the inflammatory balance?
    Thromb Haemost. 2020 Dec 22. doi: 10.1055/a-1342-3648.
    PubMed     Abstract available
    
    
    
16. CAO YX, Zhang HW, Jin JL, Liu HH, et al
    Lipoprotein(a) and cardiovascular outcomes in patients with previous myocardial infarction: a prospective cohort study.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2109.
    PubMed     Abstract available
    
    
    
17. KAZEM N, Hofer F, Koller L, Hammer A, et al
    The age-specific impact of cellular immunity on long-term outcome after acute coronary syndrome.
    Thromb Haemost. 2020 Dec 18. doi: 10.1055/a-1340-2055.
    PubMed     Abstract available
    
    
    
18. FABER J, Hvas AM, Kristensen SD, Grove EL, et al
    Immature Platelets and Risk of Cardiovascular Events among Patients with Ischemic Heart Disease: A Systematic Review.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721386.
    PubMed     Abstract available
    
    
    
19. LAINE M, Panagides V, Frere C, Cuisset T, et al
    On-ticagrelor platelet reactivity and clinical outcome in patients undergoing percutaneous coronary intervention for acute coronary syndrome.
    Thromb Haemost. 2020 Dec 1. doi: 10.1055/a-1326-5110.
    PubMed     Abstract available
    
    
    November 2020
20. MONTALTO C, Ferlini M, Casula M, Mandurino-Mirizzi A, et al
    DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/s-0040-1721145.
    PubMed    
    
    
    
21. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available
    
    
    
22. KIM HK, Tantry US, Smith SC Jr, Jeong MH, et al
    The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718729.
    PubMed     Abstract available
    
    
    October 2020
23. ZHENG YY, Wu TT, Gao Y, Guo QQ, et al
    A Novel ABC Score Predicts Mortality in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Who underwent Percutaneous Coronary Intervention.
    Thromb Haemost. 2020 Oct 31. doi: 10.1055/s-0040-1718411.
    PubMed     Abstract available
    
    
    
24. GENCER S, Lacy M, Atzler D, van der Vorst EPC, et al
    Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19.
    Thromb Haemost. 2020 Oct 29. doi: 10.1055/s-0040-1718735.
    PubMed     Abstract available
    
    
    
25. GUILLET B, Cayla G, Lebreton A, Trillot N, et al
    Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718410.
    PubMed     Abstract available
    
    
    March 2020
26. PANDEY AK, Xu K, Zhang L, Gupta S, et al
    Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Thromb Haemost. 2020;120:484-494.
    PubMed     Abstract available
    
    
    
27. RAMOTOWSKI B, Gurbel PA, Tantry U, Bracha JS, et al
    Effect of Smoking Cessation on the Pharmacokinetics and Pharmacodynamics of Clopidogrel after PCI: The Smoking Cessation Paradox Study.
    Thromb Haemost. 2020;120:449-456.
    PubMed     Abstract available
    
    
    February 2020
28. KNOPP T, Karbach S, Wenzel P
    Myeloid Cells to the Rescue: Improving Thrombus Resolution.
    Thromb Haemost. 2020;120:197-198.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: